Gadolinium-based contrast agents in pediatric MRI: renal safety, risk mitigation, and emerging alternatives
Pediatric Radiology · 07.04.2026
DOI: 10.1007/s00247-026-06584-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Radiology, online erschienen am 07.04.2026. Verfasst von Matthew M Jones und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Indiana University, 705 Riley Hospital Drive, Room 1053, Indianapolis, IN, 46202, USA. matmjone@iu.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gadolinium-based contrast agents (GBCAs) are integral to pediatric magnetic resonance imaging (MRI), yet their use requires thoughtful consideration due to developmental differences in renal function, concerns about gadolinium retention, and the rare but serious risk of nephrogenic systemic sclerosis (NSF). This review summarizes current knowledge on GBCA molecular structure, pediatric-specific pharmacokinetics, and the spectrum of known adverse effects. We discuss practical, evidence-based strategies for risk mitigation, including identifying children at increased risk, avoiding group I and III agents when eGFR is
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Imaging Sciences, Indiana University, 705 Riley Hospital Drive, Room 1053, Indianapolis, IN, 46202, USA. matmjone@iu.edu.
- Department of Pediatrics, Indiana University, Indianapolis, IN, USA.
- Department of Radiology and Imaging Sciences, Indiana University, 705 Riley Hospital Drive, Room 1053, Indianapolis, IN, 46202, USA.
- Department of Radiology and Imaging Sciences, Indiana University, 705 Riley Hospital Drive, Room 1053, Indianapolis, IN, 46202, USA. mforbesa@iu.edu.
Zitieren
APA
Jones, M. M., Boakye, A. A., Dave, N., Whitman, A. M., & Forbes-Amrhein, M. M. (2026). Gadolinium-based contrast agents in pediatric MRI: renal safety, risk mitigation, and emerging alternatives. Pediatric Radiology. https://doi.org/10.1007/s00247-026-06584-4
Vancouver
Jones MM, Boakye AA, Dave N, Whitman AM, Forbes-Amrhein MM. Gadolinium-based contrast agents in pediatric MRI: renal safety, risk mitigation, and emerging alternatives. Pediatric Radiology. 2026. doi:10.1007/s00247-026-06584-4
BibTeX
@article{Jones2026,
author = {Jones, Matthew M and Boakye, Amma A and Dave, Nirali and Whitman, Abbie M and Forbes-Amrhein, Monica M},
title = {Gadolinium-based contrast agents in pediatric MRI: renal safety, risk mitigation, and emerging alternatives},
journal = {Pediatric Radiology},
year = {2026},
doi = {10.1007/s00247-026-06584-4}
}
EUVIMED